Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

New Database: Pharmaceutical Drug Import to Russia from EEU Countries

Thursday, April 5, 2018

In 2011, the post-Soviet countries started to build a single customs zone. As a result, the transport control was placed on the external borders of the member countries, and the domestic transportation of products became untraceable. In 2017, Russia imported 8.4 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices), which is in monetary terms 9.1% higher than that of 2016. In physical terms, Russia imported nearly 212 mln units of drugs, which is 3.5% lower than that of 2016.

In 2011, the post-Soviet countries started to build a single customs zone. As a result, the transport control was placed on the external borders of the member countries, and the domestic transportation of products became untraceable. In 2017, Russia imported 8.4 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices), which is in monetary terms 9.1% higher than that of 2016. In physical terms, Russia imported nearly 212 mln units of drugs, which is 3.5% lower than that of 2016.

A number of Russian companies place the production of certain drugs on a contract basis in Belarus. In 2017, Russia imported 6 of those drugs. The leader in monetary terms is Next Uno Express (Otcpharm), which is produced at Minskintercaps facilities. Calcium Folinate VIAL (Alvils) comes second, with the import having increased by nearly 11 times over the year.

Belarus is followed by Kazakhstan. Russia imported pharmaceutical drugs from 3 Kazakh companies, which is around 14% of the import in monetary terms. Armenia is the last one, with 1%. Russia imports 7 drugs by Yerevan Chemical and Pharmaceutical Company, which is the only Armenian company that produces drugs for Russia. Thiamine chloride is the most imported drug from Armenia. Pharmaceutical drug producers from Kyrgyzstan are unable to offer anything to Russia yet.

Volume and dynamics of pharmaceutical drug import to Russia from EUU countries (wholesale prices, VAT included)

Share: